Fund HoldingsAvoro Capital Advisors LLC

Total Portfolio Value
$6.41B
Total Bought
$879.60M
Total Sold
$745.86M
Net Transaction
+$133.74M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
BLUEPRINT MEDICINES CORP1,185,0003,850,000+2,665,000103,356340,7645.32%+237,408
ASCENDIS PHARMA(ASND)5,103,0555,218,000+114,945702,538813,27712.69%+110,740
KRYSTAL BIOTECH INC(KRYS)2,628,8222,731,000+102,178411,831492,3997.69%+80,568
SOLENO THERAPEUTICS INC2,525,0002,525,0000113,499180,4112.82%+66,913
CENTESSA PHARMACEUTICALS PLC04,050,000+4,050,000058,2390.91%+58,239
MADRIGAL PHARMACEUTICALS INC(MDGL)2,029,0002,022,222-6,778626,089669,82110.46%+43,732
MERUS N V2,125,0003,000,000+875,00089,356126,2701.97%+36,914
89BIO INC4,100,0006,350,000+2,250,00032,06246,1650.72%+14,103
ALKERMES PLC(ALKS)2,450,0002,450,000070,46280,8991.26%+10,437
AVIDITY BIOSCIENCES INC7,500,0007,625,000+125,000218,100225,0903.51%+6,990
WHITEHAWK THERAPEUTICS INC2,849,4022,849,40208,9905,0720.08%-3,918
ULTRAGENYX PHARMACEUTICAL INC(RARE)830,000830,000034,91830,0540.47%-4,864
TAYSHA GENE THERAPIES INC(TSHA)19,999,99919,999,999034,60027,8000.43%-6,800
AUTOLUS THERAPEUTICS PLC9,910,6429,910,642023,29015,3610.24%-7,929
TOURMALINE BIO INC2,222,2222,425,000+202,77845,06736,8840.58%-8,182
MONTE ROSA THERAPEUTICS INC(GLUE)4,345,0004,645,548+300,54830,15421,5550.34%-8,599
OLEMA PHARMACEUTICALS INC(OLMA)1,651,9820-1,651,9829,6310-9,631
OCULAR THERAPEUTIX INC(OCUL)8,060,0008,060,000068,83259,0800.92%-9,753
MANNKIND CORP(MNKD)8,750,0008,750,000056,26344,0130.69%-12,250
ROCKET PHARMACEUTICALS INC1,200,0000-1,200,00015,0840-15,084
UNIQURE NV(QURE)2,175,0002,175,000038,41123,0550.36%-15,355
SEPTERNA INC(SEPN)1,110,0001,337,500+227,50025,4197,7440.12%-17,675
KURA ONCOLOGY INC(KURA)2,250,0000-2,250,00019,5980-19,597
CG ONCOLOGY INC(CGON)700,0000-700,00020,0760-20,076
BIOCRYST PHARMACEUTICALS INC(BCRX)11,865,0008,700,000-3,165,00089,22565,2501.02%-23,975
IOVANCE BIOTHERAPEUTICS INC(IOVA)3,500,0000-3,500,00025,9000-25,900
XENON PHARMACEUTICALS INC(XENE)5,666,6665,741,666+75,000222,133192,6333.01%-29,500
SYNDAX PHARMACEUTICALS INC(SNDX)2,275,0000-2,275,00030,0760-30,075
KYMERA THERAPEUTICS INC(KYMR)5,150,0006,460,000+1,310,000207,185176,8102.76%-30,374
ARGENX SE(ARGX)1,238,4671,235,177-3,290761,657731,05811.41%-30,599
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)2,770,1002,770,1000150,001108,2281.69%-41,773
AMICUS THERAPEUTICS INC.
COM
23,175,00020,500,000-2,675,000218,309167,2802.61%-51,028
VAXCYTE INC(PCVX)1,175,0001,000,000-175,00096,18637,7600.59%-58,425
ARROWHEAD PHARMACEUTICALS INC.(ARWR)11,111,11111,111,1110208,889141,5562.21%-67,333
BIOMARIN PHARMACEUTICAL INC(BMRN)1,462,5000-1,462,50096,1300-96,130
VERA THERAPEUTICS INC(VERA)5,610,0005,701,900+91,900237,247136,9602.14%-100,287
APELLIS PHARMACEUTICALS INC.
COM
12,222,22212,222,2220390,011267,3004.17%-122,711
SAREPTA THERAPEUTICS INC(SRPT)2,555,5552,674,835+119,280310,730170,7082.66%-140,022
UNITED THERAPEUTICS CORP(UTHR)2,760,3002,675,000-85,300973,944824,62212.87%-149,322
INTRA-CELLULAR THERAPIES INC3,050,000625,000-2,425,000254,73682,4501.29%-172,286
Page 1 of 1